Xenon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. 

CEO
Ian C. Mortimer
CEOIan C. Mortimer
Employees
327
Employees327
Headquarters
Burnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded
1996
Founded1996
Employees
327
Employees327

XENE Key Statistics

Market cap
3.44B
Market cap3.44B
Price-Earnings ratio
-11.46
Price-Earnings ratio-11.46
Dividend yield
Dividend yield
Average volume
841.99K
Average volume841.99K
High today
$46.56
High today$46.56
Low today
$43.59
Low today$43.59
Open price
$45.50
Open price$45.50
Volume
971.17K
Volume971.17K
52 Week high
$46.60
52 Week high$46.60
52 Week low
$26.74
52 Week low$26.74

Stock Snapshot

Xenon Pharmaceuticals(XENE) stock is priced at $44.53, giving the company a market capitalization of 3.44B. It carries a P/E multiple of -11.46.

On 2025-12-09, Xenon Pharmaceuticals(XENE) stock moved within a range of $43.59 to $46.56. With shares now at $44.53, the stock is trading +2.2% above its intraday low and -4.4% below the session's peak.

Trading activity shows a volume of 971.17K, compared to an average daily volume of 841.99K.

Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $46.60 and a low of $26.74.

Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $46.60 and a low of $26.74.

XENE News

Simply Wall St 4d
Evaluating Xenon Pharmaceuticals’s Valuation After Its Recent Share Price Rebound

Xenon Pharmaceuticals (XENE) has quietly outperformed the market over the past month, climbing about 15% even as many biotech peers tread water and putting its...

Evaluating Xenon Pharmaceuticals’s Valuation After Its Recent Share Price Rebound
TipRanks 4d
Xenon Pharmaceuticals Unveils Promising Long-Term Epilepsy Treatment Data

TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...

Analyst ratings

100%

of 20 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.